Molecules 2014, 19
13184
Cholesteryl 4-(2,4-dioxo-5-fluoro(1H,3H)-pyrimidin-1-yl)-4-oxobutanoate (4). Yield 4.3 g, 72%, mp
−
1
2
1
1
0
15–217 °C; IR spectra (KBr, cm ): 661, 749, 819 (C-H alkene), 1129, 1169 (C-O), 1247 (C-N 5-FU),
464 (C=C), 1521 (C=C 5-FU), 1636 (C=O amide), 1705 (C=O 5-FU), 1709 (carboxylic acid C=O),
1
738 (ester C=O), 1746 (C=O 5-FU), 2966 (C-H aliphatic), 3340 (NH). H-NMR (CDCl
3
, δ ppm):
.65–1.98 (41H cholesteryl), 2.25–2.65, (m, 4H, >N-OCCH CH CO-O-C<), 3.62–3.66 (m, 1H, OCH
2
2
1
3
cholesteryl), 5.46 (m, 1H, CCH cholesteryl), 6.6 (s, 1H, 5-FU-N3), 7.72 (s, 1H, 5-FU-C4). C-NMR
CDCl , δ ppm): 11.5-27-56.08 (24C cholesteryl and 2C succinyl), 73.18 (OCH cholesteryl), 121.9,
39.3 (C=C cholesteryl), 126.03 (5-FU-C4), 140.67 (5-FU-C5), 157.93 (5-FU-C2), 162.1 (5-FU-C6),
71.3, 173.2 (2C CO-succinoyl). Anal. calcd. for C H FN O : C, 70.20; H, 8.58; N, 4.68. Found: C,
(
3
1
1
6
3
5
51
2
5
9.89; H, 8.41; N, 4.93.
Cholesteryl 4-(2,4-dioxo-5-fluoro(1H,3H)-pyrimidin-1-yl)-4-oxobut-2-enoate (5). Yield 3.8 g, 65%,
−
1
mp 143–144 °C; IR spectra (KBr, cm ): IR spectra (KBr disk): 668, 800, 839 (C-H alkene), 1023,
1
1
0
055 (C-O), 1239 (C-N 5-FU), 1457 (C=C), 1559 (C=C 5-FU), 1653 (C=O amide), 1700 (C=O 5-FU),
1
734 (ester C=O), 1750 (C=O 5-FU), 2931 (C-H aliphatic), 3420 (NH). H-NMR (CDCl , δ ppm):
3
.64–2.3 (43H cholesteryl), 3.43–3.57 (m, 1H, OCH cholesteryl), 5.43–5.57 (m, 3H, 2 CH= maleic
1
3
acid and CCH cholesteryl), 6.48 (s, 1H, 5-FU-N3), 7.41 (s, 1H, 5-FU-C4). C-NMR (CDCl
1.83–56.71 (24C cholesteryl), 71.27 (OCH cholesteryl), 121.29, 125.18, 130.53, 139.7, 141.08 (C=C
cholesteryl, 5-FU-C5, C=C maleic acid), 153.32 (5-FU-C2), 160.2 (5-FU-C6), 162.1 (5-FU-C6), 161.4,
3
, δ ppm):
1
1
64.8 (2 CO-maleic). Anal. calcd. for C35
.05; N, 4.81.
2 5
H49FN O : C, 70.44; H, 8.28; N, 4.69. Found: C, 70.59; H,
8
Cholesteryl 2-((2,4-dioxo-5-fluoro(1H,3H)-pyrimidin-1-yl)carbonyl)-cyclohexanecarboxylate (6). Yield
−
1
4
.0 g, 62%, mp 192–193 °C; IR spectra (KBr, cm ): 668, 745, 812 (v C-H alkene), 1033, 1216 (C-O),
1
247 (C-N 5-FU), 1456 (C=C), 1559 (C=C 5-FU), 1651 (C=O amide), 1702 (C=O 5-FU), 1717 (C=O
1
ester), 1742 (C=O 5-FU), 2934 (C-H aliphatic), 3280 (NH). H-NMR (CDCl
3
, δ ppm): 0.66–3.10 (m,
5
3H, cholesteryl and cyclohexyl CH
cholesteryl), 6.53 (s, 1H, 5-FU-N3), 7.32 (s, 1H, 5-FU-C4). C-NMR (CDCl
34C cholesteryl and cyclohexyl), 71.27 (OCH cholesteryl), 121.29, 139.76, 141.08 (2Csp2 cholesteryl
and 5-FU-C5), 157.03 (5-FU-C2), 160.23 (5-FU-C6), 161.6 (5-FU-C6), 174.1, 174.8 (2 CO-cyclohexyl).
Anal. calcd. for C39 : C, 71.75; H, 8.80; N, 4.29. Found: C, 71.61; H, 8.72; N, 4.45.
2
), 3.41–3.54 (m, 1H, OCH cholesteryl), 5.37–5.45 (m, 1H, CCH
1
3
3
, δ ppm): 11.83–56.71
(
2 5
H57FN O
3
.4. Biological Evaluation
3
.4.1. Cell Culture and Cytotoxicity Assay
MDA-MB-231 breast cancer and lovo colon cells were purchased from the American Type Culture
Collection (ATCC, Rockville, MD, USA). Cells were maintained in RPMI 1640 (Sigma),
supplemented with 10% FCS (Cambrex Bio Science, Baltimore Inc., MD, USA), 100 IU/mL
penicillin, 100 mg/mL streptomycin and 2 mmol/L L-glutamine (Sigma).
Cells were seeded into 96-well plates at 0.6 × 104/well and incubated overnight. The medium was
replaced with fresh one containing the desired concentrations of the compounds. After 48 h, 10 μL of